SYNVIVIA, INC.

BERKELEY, CA · CIK 0002003070 · Biotech · Private

Chemically-controlled essential genes and protein engineering platform for GMO containment

synvivia.com →
Grants
$3.0M
4 awards
Sector median: 1
Raised
$54K
1 Form D · Dec 2023
34 months since last filing
Contracts
—
No federal contracts on record
Patents
6
0 granted · 6 pending
Sector median: 2

Capital Timeline

Federal above the line · equity below · node area scaled to amount
Capital and federal award history
DateEventSourceAmount
Federal grantDepartment of Health and Human Services · Phase I · Genetically Encoded Biosafety in a Therapeutically Modified Organism for Obesity$295,172
Federal grantNational Science Foundation · Phase I · SBIR Phase I:Development of a Novel Biocontainment/Biosafety Platform Using Synthetic Auxotrophs$255,910
Private capital raisedForm D · SEC$54,096
Federal grantDepartment of Health and Human Services · Phase II · Platform for Optimizing Yield and Quality of Therapeutic AAV Vector Manufacturing via Synthetic Helper Genes$1,640,169
Federal grantDepartment of Health and Human Services · Phase II · Platform for Optimizing Yield and Quality of Therapeutic AAV Vector Manufacturing via Synthetic Helper Genes$856,268
Federal grant · SBIR/STTRForm D · SEC

Peer position

Biotech · 4373 companies · ranked on federal contract value
Biotech companies ranked by federal contract value
#CompanyContractsDisclosed equity
1229Gaingels LabGenius LLC—$64K
1230EZRABIO INC.——
1231Gaius Therapeutics, Inc,—$60K
1232SYNVIVIA, INC.—$54K
1233Artemis Biosystems, Inc.—$50K
1234Factor Medical, LLC—$50K
1235Auvi Labs, Inc.—$543K

Ranked on federal contract value rather than capital raised. The equity column is the comparison worth making — companies at the same procurement position often sit at very different points in their funding history.

Founders & Team

From Form D filings · 1 related persons
  • Gabriel LopezDirector · Executive Officer

Patents

USPTO · 0 granted of 6
  • Engineered Cyclic Peptides For Enhancing Viral Productionapplication
  • Synthetic Helper Genes For Enhancing Viral Productionapplication
  • Synthetic Helper Genes For Enhancing Viral Productionapplication
  • Methods Of Selection And Use Of Engineered Cyclic Peptides For Enhancing Viral Productionapplication
  • Methods Of Selection And Use Of Engineered Cyclic Peptides For Enhancing Aav Productionapplication
  • Synthetic Helper Genes For Enhancing Viral Productionapplication

Regulatory activity · Biotech

Sector-level, not company-level

Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.